Naturcyte » CurQD Product
The CurQD® Protocol
CurQD® is a product of natural origin comprising a combination of two herbal compounds, Qura, the curcumin designed to act directly on the intestine, and Qing Dai. Both compounds have clinically demonstrated the ability to reduce intestinal inflammation as they possess potent anti-inflammatory and antioxidant properties.
The combination of both principles has been tested and validated in rigorous clinical trials.
Different CurQD® protocols have been developed, adapted to the severity of the intestinal health problem: CurQD®-1, CurQD®-3, and Qura.
The CurQD® Protocol is a supplement of natural ingredients, with an approximate duration of 8 weeks.
As simple as your gastroenterologist prescribing the most effective protocol for your specific needs, monitoring your progress with regular check-ups, and guiding you through each phase.
How does CurQD® help intestinal health?
Recent studies have revealed a new therapeutic target for the treatment of intestinal health problems, the aryl hydrocarbon receptor (AhR) pathway1.
Aryl hydrocarbon receptors line the gastrointestinal tract and, when activated, send signals to prevent chronic inflammation, repair mucosal damage, and restore intestinal immune system homeostasis1.
CurQD® contains unique molecules, Indigo and Indirrubin (QD components), which have an activating effect on the AhR pathway, helping to restore intestinal integrity and reinforcing the body’s own re-epithelializing capacity in people with intestinal health problems..
The AhR pathway is currently one of the main targets in the search for solutions to intestinal health problems.
CurQD® is the first supplement that has demonstrated, in clinical trials, its efficacy in helping to achieve intestinal health through the activation of this pathway.
Only 4 capsules per day for 8 weeks.
It’s that easy!
With CurQD® you will start a protocol scientifically validated in clinical trials, that has demonstrated its efficacy and safety for intestinal health.
Each protocol uses the most effective formulation based on your clinical situation. Protocols can be adjusted over time based on your progress and response to the supplement, to ensure the best possible results are achieved.
Your solution for gut recovery.
CurQD®: A protocol tailored to you
The CurQD® Protocol has been developed and clinically tested by world-renowned experts in gastroenterology with a distinguished reputation in the field of gut health, to complement and support the achievement of gut health.
CurQD® has been tested in benchmark clinical trials, in order to determine the most effective ratio of ingredients for each phase of the intestinal health recovery.
Your doctor will offer you the protocol that best suits your needs and will perform periodic checks and adjustments as needed in accordance with your response to the supplement, to help you restore your gut balance.
Developed by leading gastroenterology experts
CurQD® was developed at Sheba Medical Center, one of the top 10 hospitals in the world according to the Newsweek magazine, by Prof. Shomron Ben Horin, Head of Gastroenterology and Director of the Laboratory of Investigation of Gastroimmunology, and Nir Salomon, founder and director of the Integrative Gastroenterology Unitt at Sheba Medical Center.
Durante la última década, el Dr. Shomron Ben Horin y Nir Salomon han liderado la investigation of nutracéuticos para el tratamiento de la EII. Their research and clinical practice in hospitals have led to innovative advances in the development of natural, safe, and effective supplements for achieving and maintaining intestinal health.
In recent years, CurQD® has been successfully incorporated into the routine clinical practice of leading gastroenterology specialized hospitals in Israel and the USA.
References
1Hubbard TD, Murray IA, Perdew GH. Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab Dispos 2015;4:1522–5.
2Kawai S, Iijima H, Shinzaki S, et al. Indigo naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol. 2017; 52: 904-919.
Naganuma M, Sugimoto S, Mitsuyama K, et al. ; INDIGO Study Group. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis. Gastroenterology. 2018 Mar;154(4):95-947.